Tissue distribution and induction of the rat multidrug resistance- associated proteins 5 and 6

J. M. Maher, Nathan J Cherrington, A. L. Slitt, C. D. Klaassen

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Multidrug resistance-associated proteins (Mrps) are ATP-dependent transporters which transport a wide variety of anionic and cationic compounds. The purpose of this study was to determine the tissue distribution of Mrp5 and 6 in male and female Sprague-Dawley rats in various tissues, and to investigate whether the expression is altered by cholestasis or administration of microsomal enzyme inducers (MEIs). These MEIs activate six different transcriptionally- mediated pathways, and their effects on Mrp5 and Mrp6 expression were determined. The effects of bile-duct ligation, a cholestasis model, on Mrp5 and 6 expression in male rats were quantified. Mrp5 had marked expression in adrenal gland, and moderate expression in cerebral cortex, cerebellum, and stomach. The MEIs polychlorinated biphenyl (PCB)126, phenobarbital, and PCB99 slightly repressed Mrp5, but no single class of receptor agonists induced or repressed Mrp5. Bile-duct ligation tended to increase Mrp5 expression, but was not statistically significant at a 3 day timepoint. Mrp6 expression was highest in intestine, liver, and kidney. Mrp6 was slightly repressed by phenobarbital, dexamethasone, and isoniazid, but no one class of receptor agonists induced or repressed Mrp6, and expression was also unchanged bile-duct ligation. In conclusion, Mrp5 in rats is most highly expressed in the adrenal gland, whereas Mrp6 is mainly expressed in excretory organs (liver, intestine, and kidney), suggesting markedly different functions. Hepatic mRNA levels of Mrp5 or Mrp6 do not seem to be coordinately regulated along with Phase I enzymes via receptor-mediated pathways, and are not part of the hepatoprotective upregulation of basolateral transporters that occurs during cholestasis.

Original languageEnglish (US)
Pages (from-to)2219-2225
Number of pages7
JournalLife Sciences
Volume78
Issue number19
DOIs
StatePublished - Apr 4 2006

Fingerprint

Tissue Distribution
Cholestasis
Bile Ducts
Ducts
Tissue
Ligation
Rats
Enzymes
Phenobarbital
Adrenal Glands
Liver
Intestines
Multidrug Resistance-Associated Proteins
Kidney
Polychlorinated Biphenyls
Isoniazid
Cerebral Cortex
Cerebellum
Dexamethasone
Sprague Dawley Rats

Keywords

  • Mrp
  • Multidrug resistance
  • Tissue distribution
  • Transporter

ASJC Scopus subject areas

  • Pharmacology

Cite this

Tissue distribution and induction of the rat multidrug resistance- associated proteins 5 and 6. / Maher, J. M.; Cherrington, Nathan J; Slitt, A. L.; Klaassen, C. D.

In: Life Sciences, Vol. 78, No. 19, 04.04.2006, p. 2219-2225.

Research output: Contribution to journalArticle

Maher, J. M. ; Cherrington, Nathan J ; Slitt, A. L. ; Klaassen, C. D. / Tissue distribution and induction of the rat multidrug resistance- associated proteins 5 and 6. In: Life Sciences. 2006 ; Vol. 78, No. 19. pp. 2219-2225.
@article{606940278d4d4238b4c2e6b2adf594b5,
title = "Tissue distribution and induction of the rat multidrug resistance- associated proteins 5 and 6",
abstract = "Multidrug resistance-associated proteins (Mrps) are ATP-dependent transporters which transport a wide variety of anionic and cationic compounds. The purpose of this study was to determine the tissue distribution of Mrp5 and 6 in male and female Sprague-Dawley rats in various tissues, and to investigate whether the expression is altered by cholestasis or administration of microsomal enzyme inducers (MEIs). These MEIs activate six different transcriptionally- mediated pathways, and their effects on Mrp5 and Mrp6 expression were determined. The effects of bile-duct ligation, a cholestasis model, on Mrp5 and 6 expression in male rats were quantified. Mrp5 had marked expression in adrenal gland, and moderate expression in cerebral cortex, cerebellum, and stomach. The MEIs polychlorinated biphenyl (PCB)126, phenobarbital, and PCB99 slightly repressed Mrp5, but no single class of receptor agonists induced or repressed Mrp5. Bile-duct ligation tended to increase Mrp5 expression, but was not statistically significant at a 3 day timepoint. Mrp6 expression was highest in intestine, liver, and kidney. Mrp6 was slightly repressed by phenobarbital, dexamethasone, and isoniazid, but no one class of receptor agonists induced or repressed Mrp6, and expression was also unchanged bile-duct ligation. In conclusion, Mrp5 in rats is most highly expressed in the adrenal gland, whereas Mrp6 is mainly expressed in excretory organs (liver, intestine, and kidney), suggesting markedly different functions. Hepatic mRNA levels of Mrp5 or Mrp6 do not seem to be coordinately regulated along with Phase I enzymes via receptor-mediated pathways, and are not part of the hepatoprotective upregulation of basolateral transporters that occurs during cholestasis.",
keywords = "Mrp, Multidrug resistance, Tissue distribution, Transporter",
author = "Maher, {J. M.} and Cherrington, {Nathan J} and Slitt, {A. L.} and Klaassen, {C. D.}",
year = "2006",
month = "4",
day = "4",
doi = "10.1016/j.lfs.2005.09.016",
language = "English (US)",
volume = "78",
pages = "2219--2225",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "19",

}

TY - JOUR

T1 - Tissue distribution and induction of the rat multidrug resistance- associated proteins 5 and 6

AU - Maher, J. M.

AU - Cherrington, Nathan J

AU - Slitt, A. L.

AU - Klaassen, C. D.

PY - 2006/4/4

Y1 - 2006/4/4

N2 - Multidrug resistance-associated proteins (Mrps) are ATP-dependent transporters which transport a wide variety of anionic and cationic compounds. The purpose of this study was to determine the tissue distribution of Mrp5 and 6 in male and female Sprague-Dawley rats in various tissues, and to investigate whether the expression is altered by cholestasis or administration of microsomal enzyme inducers (MEIs). These MEIs activate six different transcriptionally- mediated pathways, and their effects on Mrp5 and Mrp6 expression were determined. The effects of bile-duct ligation, a cholestasis model, on Mrp5 and 6 expression in male rats were quantified. Mrp5 had marked expression in adrenal gland, and moderate expression in cerebral cortex, cerebellum, and stomach. The MEIs polychlorinated biphenyl (PCB)126, phenobarbital, and PCB99 slightly repressed Mrp5, but no single class of receptor agonists induced or repressed Mrp5. Bile-duct ligation tended to increase Mrp5 expression, but was not statistically significant at a 3 day timepoint. Mrp6 expression was highest in intestine, liver, and kidney. Mrp6 was slightly repressed by phenobarbital, dexamethasone, and isoniazid, but no one class of receptor agonists induced or repressed Mrp6, and expression was also unchanged bile-duct ligation. In conclusion, Mrp5 in rats is most highly expressed in the adrenal gland, whereas Mrp6 is mainly expressed in excretory organs (liver, intestine, and kidney), suggesting markedly different functions. Hepatic mRNA levels of Mrp5 or Mrp6 do not seem to be coordinately regulated along with Phase I enzymes via receptor-mediated pathways, and are not part of the hepatoprotective upregulation of basolateral transporters that occurs during cholestasis.

AB - Multidrug resistance-associated proteins (Mrps) are ATP-dependent transporters which transport a wide variety of anionic and cationic compounds. The purpose of this study was to determine the tissue distribution of Mrp5 and 6 in male and female Sprague-Dawley rats in various tissues, and to investigate whether the expression is altered by cholestasis or administration of microsomal enzyme inducers (MEIs). These MEIs activate six different transcriptionally- mediated pathways, and their effects on Mrp5 and Mrp6 expression were determined. The effects of bile-duct ligation, a cholestasis model, on Mrp5 and 6 expression in male rats were quantified. Mrp5 had marked expression in adrenal gland, and moderate expression in cerebral cortex, cerebellum, and stomach. The MEIs polychlorinated biphenyl (PCB)126, phenobarbital, and PCB99 slightly repressed Mrp5, but no single class of receptor agonists induced or repressed Mrp5. Bile-duct ligation tended to increase Mrp5 expression, but was not statistically significant at a 3 day timepoint. Mrp6 expression was highest in intestine, liver, and kidney. Mrp6 was slightly repressed by phenobarbital, dexamethasone, and isoniazid, but no one class of receptor agonists induced or repressed Mrp6, and expression was also unchanged bile-duct ligation. In conclusion, Mrp5 in rats is most highly expressed in the adrenal gland, whereas Mrp6 is mainly expressed in excretory organs (liver, intestine, and kidney), suggesting markedly different functions. Hepatic mRNA levels of Mrp5 or Mrp6 do not seem to be coordinately regulated along with Phase I enzymes via receptor-mediated pathways, and are not part of the hepatoprotective upregulation of basolateral transporters that occurs during cholestasis.

KW - Mrp

KW - Multidrug resistance

KW - Tissue distribution

KW - Transporter

UR - http://www.scopus.com/inward/record.url?scp=33645222292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645222292&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2005.09.016

DO - 10.1016/j.lfs.2005.09.016

M3 - Article

VL - 78

SP - 2219

EP - 2225

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 19

ER -